Aurobindo Pharma appoints Dr Satakarni Makkapati as Non executive, Non independent Director
Hyderabad: Aurobindo Pharma has recently announced the appointment of Dr Satakarni Makkapati as Non-executive and Non-independent Director of the Company with effect from November 9, 2023.
"The Board of Directors of the Company at its meeting held on November 9, 2023, has, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of the members through postal ballot, approved the appointment of Dr.Satakarni Makkapati (DIN. 09377266) as Non-executive and Nonindependent Director of the Company with effect from November 9, 2023," the Company informed in a BSE filing.
He is not related to any Director / Key Managerial Personnel of the Company.
Dr. Satakarni Makkapati is the Chief Executive Officer of Biologics, Vaccines and Peptides businesses at Aurobindo Pharma Ltd. Dr. Satakarni joined Aurobindo Pharma in 2016 as President, Biologics Division. During this time, he has helped envision and build a Biologics Organization from scratch by crafting business strategy, organising top-notch infrastructure and talented human resources. Previously, he was heading Intas’s Biopharma and Celestial Business Divisions integrating efforts across the value chain from early-stage development to commercial manufacturing and business development. Satakarni also had scientific functional leadership stints earlier in his career at Hospira Adelaide Pty Ltd and Dr. Reddy’s Laboratories. During his PhD defence period, he was associated as a Fermentation Scientist with the prestigious Clare Hall Laboratories of Cancer Research UK, which is a leading centre for studies of DNA repair, recombination and replication, cell cycle control and transcription. Dr. Satakarni obtained his executive training with a Master’s in Business Administration (MBA) from the IMD Business School at Lausanne (Switzerland), Doctor of Philosophy (PhD) in Faculty of Physical Sciences and Engineering from the member of prestigious association of The Russell Group at the University of Manchester (UK) and a Bachelor’s Degree in Chemical Engineering. When at IMD, Satakarni was recognized and listed by Poets and Quants for the class of 2015, across all leading business schools in the US and the EU. Dr. Satakarni currently serves on the Telangana Life Sciences Advisory Committee and on the Board of School of Life Sciences at Hyderabad Central University.
Read also: Aurobindo Pharma arm bags USFDA nod for Testosterone Cypionate Injection
